Cue Biopharma, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2021
Total Assets: $83.4M
Liabilities Breakdown FY2021
Total Liabilities: $17.9M
Asset Breakdown
Total Assets: $83.4M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $64.4M | 77.2% |
| Accounts Receivable | $3.1M | 3.8% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $2.1M | 2.5% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $13.8M | 16.5% |
Liabilities Breakdown
Total Liabilities: $17.9M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $2.6M | 14.5% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $15.3M | 85.5% |